Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|December 26, 2012
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responsesHyun-Il Cho, Kelly Barrios, Young-Ran Lee, et al.
BMC Complementary and Alternative Medicine|December 2, 2009
Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized miceMike Burrows, Deepak Assundani, Esteban Celis, et al.
Cancer Research|February 7, 2007
Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumorsPilar Nava-Parada, Guido Forni, Keith L Knutson, et al.
Cancer Research|March 17, 2007
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2019
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in miceHussein Sultan, Takumi Kumai, Toshihiro Nagato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytesJun Lu, Robert L Giuntoli, Ryusuke Omiya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
Mechanism of T cell tolerance induced by myeloid-derived suppressor cellsSrinivas Nagaraj, Adam G Schrum, Hyun-Il Cho, et al.
Cytokine|January 12, 2010
Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma modelAmer N Kalaaji, Jun Lu, Svetomir N Markovic, et al.
International Journal of Cancer|November 28, 2008
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic miceAsim Saha, Malaya Bhattacharya-Chatterjee, Kenneth A Foon, et al.
Journal of Translational Medicine|September 22, 2014
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitorTakumi Kumai, Kensuke Oikawa, Naoko Aoki, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|December 26, 2012
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responsesHyun-Il Cho, Kelly Barrios, Young-Ran Lee, et al.
BMC Complementary and Alternative Medicine|December 2, 2009
Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized miceMike Burrows, Deepak Assundani, Esteban Celis, et al.
Cancer Research|February 7, 2007
Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumorsPilar Nava-Parada, Guido Forni, Keith L Knutson, et al.
Cancer Research|March 17, 2007
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigenAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2019
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in miceHussein Sultan, Takumi Kumai, Toshihiro Nagato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytesJun Lu, Robert L Giuntoli, Ryusuke Omiya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
Mechanism of T cell tolerance induced by myeloid-derived suppressor cellsSrinivas Nagaraj, Adam G Schrum, Hyun-Il Cho, et al.
Cytokine|January 12, 2010
Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma modelAmer N Kalaaji, Jun Lu, Svetomir N Markovic, et al.
International Journal of Cancer|November 28, 2008
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic miceAsim Saha, Malaya Bhattacharya-Chatterjee, Kenneth A Foon, et al.
Journal of Translational Medicine|September 22, 2014
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitorTakumi Kumai, Kensuke Oikawa, Naoko Aoki, et al.
Pageof 13